⌘K
Loading ticker…
LENZ Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, LENZ Therapeutics, Inc. Common Stock (LENZ) has a 3-month relative strength percentile of 9 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 29. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.1%, relative volume 2.78×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
9 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
LENZ is in a stage 4 downtrend, week 12. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -26.0% / -69.7%.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
LENZ is held by 5 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $7M notional. Top 3 carry $14M.
Top 5 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $7M |
| IWMiShares Russell 2000 ETF | 0.01% | $4M |
| VXFVanguard Extended Market ETF | 0.00% | $2M |
| IWOiShares Russell 2000 Growth ETF | 0.01% | $1M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $235K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LENZ Jan avg: -6.35% median: -6.35% win: 0% σ: 7.38% n: 2 2024-03-25 → 2026-05-29 | LENZ Feb avg: -14.61% median: -14.61% win: 0% σ: 0.17% n: 2 2024-03-25 → 2026-05-29 | LENZ Mar avg: 7.81% median: 17.77% win: 67% σ: 36.05% n: 3 2024-03-25 → 2026-05-29 | LENZ Apr avg: -6.63% median: -1.86% win: 33% σ: 20.34% n: 3 2024-03-25 → 2026-05-29 | LENZ May avg: -4.87% median: -3.65% win: 33% σ: 7.95% n: 3 2024-03-25 → 2026-05-29 | LENZ Jun avg: 6.73% median: 6.73% win: 100% σ: 8.98% n: 2 2024-03-25 → 2026-05-29 (current) | LENZ Jul avg: 22.59% median: 22.59% win: 100% σ: 29.73% n: 2 2024-03-25 → 2026-05-29 | LENZ Aug avg: 11.98% median: 11.98% win: 50% σ: 25.14% n: 2 2024-03-25 → 2026-05-29 | LENZ Sep avg: 11.04% median: 11.04% win: 100% σ: 13.49% n: 2 2024-03-25 → 2026-05-29 | LENZ Oct avg: -11.32% median: -11.32% win: 50% σ: 35.19% n: 2 2024-03-25 → 2026-05-29 | LENZ Nov avg: 17.37% median: 17.37% win: 100% σ: 20.76% n: 2 2024-03-25 → 2026-05-29 | LENZ Dec avg: -33.24% median: -33.24% win: 0% σ: 20.27% n: 2 2024-03-25 → 2026-05-29 |